New antiviral agents
Copyright policy )New antiviral agents
During the last three decades, a better understanding of viral replication and disease states caused by viral infections have led to the development of newer antiviral agents with enhanced activity and better tolerability. This review focuses on newer systemic and topical antiviral agents that are used in treatment of herpes viruses including herpes simplex type-1 (HSV-1) and type-2 (HSV-2), varicella-zoster virus (VZV) and cytomegalovirus CMV) as well as the human papilloma virus (HPV). Included in this article are the agents famciclovir, penciclovir, valganciclovir, imiquimod, docosanole and brivudin.
- Boston Children's Hospital United States
- Wayne State University United States
- Wayne State College United States
- Children's Hospital of Michigan United States
Guanine, Imiquimod, Famciclovir, Acyclovir, Antiviral Agents, Bromodeoxyuridine, Virus Diseases, Aminoquinolines, Humans, Valganciclovir, Fatty Alcohols, 2-Aminopurine, Ganciclovir
Guanine, Imiquimod, Famciclovir, Acyclovir, Antiviral Agents, Bromodeoxyuridine, Virus Diseases, Aminoquinolines, Humans, Valganciclovir, Fatty Alcohols, 2-Aminopurine, Ganciclovir
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).16 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!